Literature DB >> 19111760

Current perceptions of the epidemiology of atrial fibrillation.

William B Kannel1, Emelia J Benjamin.   

Abstract

Atrial fibrillation (AF), an escalating dysrhythmia, is accountable for extensive population morbidity and mortality. In the United States, approximately 2.3 million people are presently diagnosed with AF and it is estimated that this prevalence may increase to 5.6 million by 2050. Foremost predisposing risk factors for this dysrhythmia include advanced age and cardiovascular disease and its risk factors. The chief hazard of AF is embolic stroke, which is increased four- to fivefold, and in advanced age, it becomes a dominant stroke risk factor. AF also carries a doubled mortality rate.

Entities:  

Mesh:

Year:  2009        PMID: 19111760      PMCID: PMC2917063          DOI: 10.1016/j.ccl.2008.09.015

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  77 in total

1.  Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure.

Authors:  J Krieger; L Laks; I Wilcox; R R Grunstein; L J Costas; J G McDougall; C E Sullivan
Journal:  Clin Sci (Lond)       Date:  1989-10       Impact factor: 6.124

2.  Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States.

Authors:  Karin S Coyne; Clark Paramore; Susan Grandy; Marco Mercader; Matthew Reynolds; Peter Zimetbaum
Journal:  Value Health       Date:  2006 Sep-Oct       Impact factor: 5.725

3.  Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986--1996.

Authors:  S Stewart; K MacIntyre; M M MacLeod; A E Bailey; S Capewell; J J McMurray
Journal:  Eur Heart J       Date:  2001-04       Impact factor: 29.983

4.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

5.  Atrial and ventricular arrhythmias in asymptomatic active elderly subjects: correlation with left atrial size and left ventricular mass.

Authors:  D E Manyari; C Patterson; D Johnson; L Melendez; W J Kostuk; R D Cape
Journal:  Am Heart J       Date:  1990-05       Impact factor: 4.749

6.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

7.  Obstructive sleep apnea and the recurrence of atrial fibrillation.

Authors:  Ravi Kanagala; Narayana S Murali; Paul A Friedman; Naser M Ammash; Bernard J Gersh; Karla V Ballman; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

8.  Familial atrial fibrillation is a genetically heterogeneous disorder.

Authors:  Dawood Darbar; Kathleen J Herron; Jeffrey D Ballew; Arshad Jahangir; Bernard J Gersh; Win-K Shen; Stephen C Hammill; Douglas L Packer; Timothy M Olson
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

9.  Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study.

Authors:  M C Kanter; C H Tegeler; L A Pearce; J Weinberger; W M Feinberg; D C Anderson; C R Gomez; J F Rothrock; C M Helgason; R G Hart
Journal:  Arch Intern Med       Date:  1994-06-27

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  40 in total

1.  Predicting the need for hospital admission of TIA patients.

Authors:  Indrani Acosta; Sivan Bloch; Miriam Morales; Natan M Bornstein; Sean I Savitz; Hen Hallevi
Journal:  J Neurol Sci       Date:  2013-10-14       Impact factor: 3.181

2.  Inflammatory responses in the atria: should they stay or should they go?

Authors:  Heather S Duffy
Journal:  Heart Rhythm       Date:  2010-11-05       Impact factor: 6.343

3.  Genome-wide Study of Atrial Fibrillation Identifies Seven Risk Loci and Highlights Biological Pathways and Regulatory Elements Involved in Cardiac Development.

Authors:  Jonas B Nielsen; Lars G Fritsche; Wei Zhou; Tanya M Teslovich; Oddgeir L Holmen; Stefan Gustafsson; Maiken E Gabrielsen; Ellen M Schmidt; Robin Beaumont; Brooke N Wolford; Maoxuan Lin; Chad M Brummett; Michael H Preuss; Lena Refsgaard; Erwin P Bottinger; Sarah E Graham; Ida Surakka; Yunhan Chu; Anne Heidi Skogholt; Håvard Dalen; Alan P Boyle; Hakan Oral; Todd J Herron; Jacob Kitzman; José Jalife; Jesper H Svendsen; Morten S Olesen; Inger Njølstad; Maja-Lisa Løchen; Aris Baras; Omri Gottesman; Anthony Marcketta; Colm O'Dushlaine; Marylyn D Ritchie; Tom Wilsgaard; Ruth J F Loos; Timothy M Frayling; Michael Boehnke; Erik Ingelsson; David J Carey; Frederick E Dewey; Hyun M Kang; Gonçalo R Abecasis; Kristian Hveem; Cristen J Willer
Journal:  Am J Hum Genet       Date:  2017-12-28       Impact factor: 11.025

Review 4.  Gender Differences in Arrhythmias: Focused on Atrial Fibrillation.

Authors:  Xiao-Ting Tian; Ying-Jia Xu; Yi-Qing Yang
Journal:  J Cardiovasc Transl Res       Date:  2019-10-21       Impact factor: 4.132

5.  Gender and Racial Characteristics of Patients Referred to a Tertiary Atrial Fibrillation Center.

Authors:  Pamela K Mason; Liza Moorman; Douglas E Lake; J Michael Mangrum; John P DiMarco; John D Ferguson; Srijoy Mahapatra; Kenneth C Bilchick; David Wiggins; J Paul Mounsey; J Randall Moorman
Journal:  J Atr Fibrillation       Date:  2010-12-15

Review 6.  Role of PR-Interval In Predicting the Occurrence of Atrial Fibrillation.

Authors:  Signe Bidstrup; Morten Salling Olesen; Jesper Hastrup Svendsen; Jonas Bille Nielsen
Journal:  J Atr Fibrillation       Date:  2013-12-31

Review 7.  Recent advances in the molecular pathophysiology of atrial fibrillation.

Authors:  Reza Wakili; Niels Voigt; Stefan Kääb; Dobromir Dobrev; Stanley Nattel
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

8.  Atrial fibrillation in myocardial infarction patients: Impact on health care utilization.

Authors:  Alanna M Chamberlain; Suzette J Bielinski; Susan A Weston; Winslow Klaskala; Roger M Mills; Bernard J Gersh; Alvaro Alonso; Véronique L Roger
Journal:  Am Heart J       Date:  2013-08-17       Impact factor: 4.749

9.  Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts.

Authors:  Hassan Musa; Kuljeet Kaur; Ryan O'Connell; Matt Klos; Guadalupe Guerrero-Serna; Uma Mahesh R Avula; Todd J Herron; Jerômé Kalifa; Justus M B Anumonwo; José Jalife
Journal:  Heart Rhythm       Date:  2013-03-14       Impact factor: 6.343

10.  Chronic exercise: a contributing factor to atrial fibrillation?

Authors:  Xander H T Wehrens; David Y Chiang; Na Li
Journal:  J Am Coll Cardiol       Date:  2013-04-09       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.